midazolam and cinacalcet

midazolam has been researched along with cinacalcet in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Emery, M; Padhi, D; Salfi, M	1
Bi, J; Enoki, Y; Fujimura, R; Fukagawa, M; Hirata, K; Ikegami, K; Imafuku, T; Ishima, Y; Jingami, S; Komaba, H; Maeda, H; Maruyama, T; Matsushita, K; Murata, M; Nishida, K; Otagiri, M; Sakaguchi, Y; Sugimoto, R; Tanaka, M; Watanabe, H	1

Reviews

1 review(s) available for midazolam and cinacalcet

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for midazolam and cinacalcet

Article	Year
Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteers. Drugs in R&D, 2008, Volume: 9, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Calcium; Calcium Channel Agonists; Cinacalcet; Cross-Over Studies; Cytochrome P-450 CYP3A; Data Interpretation, Statistical; Female; Half-Life; Humans; Hypnotics and Sedatives; Immunosuppressive Agents; Male; Midazolam; Middle Aged; Naphthalenes; Nausea; Paresthesia; Vomiting; Young Adult	2008

Article

Year

Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteers.

Drugs in R&D, 2008, Volume: 9, Issue:5

Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Calcium; Calcium Channel Agonists; Cinacalcet; Cross-Over Studies; Cytochrome P-450 CYP3A; Data Interpretation, Statistical; Female; Half-Life; Humans; Hypnotics and Sedatives; Immunosuppressive Agents; Male; Midazolam; Middle Aged; Naphthalenes; Nausea; Paresthesia; Vomiting; Young Adult

2008

Other Studies

1 other study(ies) available for midazolam and cinacalcet

Article	Year
Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism. Biochemical pharmacology, 2017, 12-01, Volume: 145 Topics: Animals; Caco-2 Cells; Cinacalcet; Cyclic AMP; Cytochrome P-450 CYP3A; Down-Regulation; GABA Modulators; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Hyperparathyroidism; Male; Midazolam; NF-kappa B; Parathyroid Hormone; Phosphatidylinositol 3-Kinases; Protein Kinase C; Random Allocation; Rats; Renal Insufficiency, Chronic; Signal Transduction	2017

Article

Year

Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism.

Biochemical pharmacology, 2017, 12-01, Volume: 145

Topics: Animals; Caco-2 Cells; Cinacalcet; Cyclic AMP; Cytochrome P-450 CYP3A; Down-Regulation; GABA Modulators; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Hyperparathyroidism; Male; Midazolam; NF-kappa B; Parathyroid Hormone; Phosphatidylinositol 3-Kinases; Protein Kinase C; Random Allocation; Rats; Renal Insufficiency, Chronic; Signal Transduction

2017